The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Dr. Yumeng Li is an associate professor in the Department of Health and Human Performance at Texas State University.
His primary research area focuses on sports and clinical biomechanics.
Chenxi Li is an Associate Professor at School of Public Administration, Xi'an University of Architecture and Technology, Xi’an, China. He has been invited as an article editor for journal of SAGE Open in 2020.He has been invited as an Associate Editor for International Journal of Environmental Science and Technology in 2021. He has authored and co-authored more than 25 papers and book chapters in his fields. His research interests include Natural Resource Management, Environmental Sciences, Land Use and Cover Change, Coupled-natural-and-human-systems, Urban-Rural Integrated Development.
Dr. Li Li is Professor of Kinesiology within the Department of Health Sciences and Kinesiology at Georgia Southern University. His research is focused on the neuromuscular coordination of human postural control, especially postural stability during standing and walking.
Dr. Li's research interests include:
- Biomechanics of human movement
- Aging
- Running injuries
- The effects of certain pathologies on human movement (especially - peripheral neuropathy, diabetes, and cerebral palsy)
- Gait analysis
Dr. Xing Li is an Assistant Professor and Associate Consultant in the Division of Biomedical Statistics and Informatics, Department of Health Science Research at Mayo Clinic - voted the best hospital by U.S. News & World Report. Dr. Li completed his PhD in Bioinformatics from The University of Michigan at Ann Arbor, Michigan, USA. Dr. Li also holds a Masters Degree in Biochemistry and Molecular Biology and Bachelors Degree in Microbiology. Dr. Li’s research interests focus on machine learning, bioinformatics, and statistical data mining in large scale data in biomedical research, such as next generation sequencing data (whole genome sequencing, RNA-seq, microarray data), in the file. He has published more than 20 peer-reviewed papers in reputable journals and book chapters in the fields of Bioinformatics and Biostatistics, cancer research, cardiovascular disease, embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) research, and human genomics, genetics and development, and Microbiology. Dr. Li’s publications have been highlighted as Journal Cover Stories, Journal Featured Articles, Highlights Section Papers, Must Read by Faculty 1000, and ESC & iPSC News, etc. Dr. Li has been developing data analysis tools, such as RCircle and PCA3d, etc. Dr. Li is also a member of American Association for Cancer Research (AACR), International Society for Computational Biology (ISCB), American Statistics Association (ASA) and American Heart Association (AHA).
Mingda completed his B.S. in Engineering Physics from Tsinghua University in 2009, and his Ph.D. in Nuclear Science and Engineering from MIT in 2015. Before joining the department as a faculty, he carried out research as a postdoc associate at Mechanical Engineering Department of MIT. His research is to study the quantum and functional properties of materials using spectroscopic methods and many-body theory, particularly interplay with materials defects.
Prof. Li received his Medical Doctorate in 2005 as an outstanding graduate of the Chinese Union Medical University (CUMU). In the same year, he worked in the Department of Thoracic Surgery at the Cancer Hospital of the Chinese Academy of Medical Sciences, where he served as an attending physician, deputy chief physician, and was appointed Chief Physician in 2019. He has a solid theoretical foundation and excellent research ability, and has accumulated rich clinical experience during my work. In 2017, he took over as the Director of the Office of Drug Clinical Trial Research Center, and his outstanding achievements in the management of clinical trial institutions and clinical and translational research, and is currently served as the chief expert of China GCP platform and Leading PI of international multicenter clinical trials of anti-cancer drug discovery. He is committed to new anti-tumor drug research, real-world research, full chain translation research of clinical trials, precision treatment of rare tumors and tumor big data research. His H-Index is 44 based on Web of Science. As a sub-project leader of the National 973 Major Project, the National Key R&D Program for Precision Medicine, the National Natural Science Foundation of China, the GCP platform leader, and the leader of the 13th and 14th Five-Year Innovation Project, he has undertaken many research projects.
Dongming Li is a Professor at the College of Life Sciences, Hebei Normal University. His research focuses on the mechanisms of how animals adjust their morphology, physiology, and behavior to respond to the changing (or extreme) environments in free-living animals, especially birds.
Dr. Jiaqi Liang is a Researcher in the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University. Her research predominantly focuses on the clinical and molecular research of lung cancer.
Professor in Bioinformatics, Biology Department, Miami University, Ohio, USA
Phd., Associate Professor of Landscape Ecology, Institute of Applied Ecology, Chinese Academy of Sciences. Head of Landscape Process Research Group.
Prof. Fernando Lidon is Full Professor within the Department of Earth Sciences in the Faculty of Science and Technology of the New University of Lisbon.
His research interests include, Phytotechnology, Food Technology, Biochemistry, Plant Physiology and Agro Industry.
Dr. Bruce Lieberman is a paleontologist and evolutionary biologist interested in macroevolution and the evolutionary history of invertebrates.